Search results
Results from the WOW.Com Content Network
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies (such as insect bites) and asthma. [1] [2] Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.
There are certain conditions that chihuahua owners should be aware of. This breed can be prone to dental disease and a condition called luxating patellas. This condition causes the kneecaps to ...
The Chihuahua has some genetic predisposition to several neurological diseases, among them atlantoaxial instability, ceroid lipofuscinosis, congenital deafness, congenital hydrocephalus, muscular dystrophy, necrotizing meningoencephalitis, and neuroaxonal dystrophy; [20]: 3 [21] it has a mild predisposition to congenital heart disease.
This therapy ties to the Hygiene hypothesis in that the lack of exposure to bacteria and parasites such as helminths can cause a weaker immune system leading to being more susceptible to autoimmune disease. [4] [5] Helminth worms are members of two phyla: nematodes, which are primarily used in human helminthic therapy, and flat worms . [2]
Chihuahuas can have two different head shapes: apple or deer. ... Folklore from bygone times suggests that Chihuahuas were able to cure various respiratory ailments, such as asthma and other ...
Signs are similar to human disease, including anorexia, fever, and thrombocytopenia. [12] Clostridium species can cause diarrhea in dogs. Associated species include C. perfringens and Clostridioides difficile. [13] Kennel cough is an infectious respiratory disease that can be caused by one of several viruses or by Bordetella bronchiseptica. It ...
Chihuahuas can grow to around six to nine inches tall (15-23cm) and anywhere between four to six pounds (1.8- 2.7 kg) when they're fully grown. This pocket-sized breed comes in both short and long ...
The TSLP signaling axis is an attractive therapeutic target. Amgen's Tezepelumab, a monoclonal antibody which blocks TSLP, is currently approved for the treatment of severe asthma. [30] [31] Fusion proteins consisting of TSLPR and IL-7Rα which can trap TSLP with excellent affinity have also been designed. [22]